ArticleThe oncologist2023

Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration.

Amanda M Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.